• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Multiple Sclerosis, Relapsing-Remitting

Multiple Sclerosis, Relapsing-Remitting - 32 Studies Found

Terminated : A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis
: Multiple Sclerosis, Relapsing-Remitting
: 2015-04-02
: Biological: Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the fla
Completed : Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
: Multiple Sclerosis, Relapsing-Remitting
: 2001-11-30
:
  • Drug: Natalizumab Natalizumab

Withdrawn : Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis
: Relapsing Remitting Multiple Sclerosis
: 2015-05-11
:
  • Drug: dimethyl fumarate dimeth

Completed : Rebif® Rebidose® Versus Rebiject II® Ease-of-Use
: Multiple Sclerosis, Relapsing-Remitting
: 2013-12-18
:
  • Device: Rebif Rebidose Rebif 4

Withdrawn : Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis
: Relapsing Remitting Multiple Sclerosis
: 2012-10-19
:
  • Drug: RNS60 125 ml
  • Drug: RNS60 250 ml